SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-051151
Filing Date
2019-09-30
Accepted
2019-09-30 18:24:47
Documents
2
Period of Report
2019-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7070
2 POA DOCUMENT poa.txt EX-24.3_873978 2958
  Complete submission text file 0001209191-19-051151.txt   11585
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRACON PHARMACEUTICALS, INC. 4350 LA JOLLA VILLAGE DRIVE, SUITE 800 SAN DIEGO CA 92122
Business Address
Brown Scott B. (Reporting) CIK: 0001789822 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36818 | Film No.: 191127156